Tabs
Mark McClellan MD, PhD; Duke-Robert J. Margolis Center for Health Policy, and Robert J. Margolis Professor of Business, Medicine and Health Policy, Duke University, Durham NC
Greg Daniel PhD, MPH; Duke-Robert J. Margolis Center for Health Policy Washington DC and Clinical Professor, Fuqua School of Business, Duke University, Durham NC
Steven Anderson PhD, MPP; Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
Kathleen Blake MD, MPH; Vice President, Performance Improvement, American Medical Association
Jeffrey Brown PhD; Associate Professor, Department of Population Medicine, Harvard Pilgrim Healthcare Institute and Harvard Medical School
Patrizia A. Cavazzoni MD; Worldwide Development Operations, Pfizer, Inc.
Francesca Cunningham PharmD; Center for Medication Safety, U.S. Department of Veterans Affairs
Gerald J. Dal Pan MD, MHS; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Bruce Fireman ; Division of Research, Kaiser Permanente Northern California
Susan Hariri PhD; Division of Viral Hepatitis, U.S. Centers for Disease Control and Prevention
Troy McCall PhD; Chief Implementation Officer, Reagan-Udall Foundation for the FDA
Catherine M. Meyers MD; Office of Clinical and Regulatory Affairs, National Center for Complementary and Integrative Health, National Institutes of Health
Mikita J. Stephen JD; Planning Board Member, Sentinel, Lead, Sentinel Engagement Partners Workgroup, Patient Representative, Duke Clinical Trials Transformation Initiative;
Gregroy Pappas MD, PhD; National Device Surveillance, Office of Surveillance and Biometrics, Center for Devices and Radiological Health, U.S. Food and Drug Administration
Doris Peter PhD; Health Ratings Center, Consumer Reports
Richard Platt MD, MSc; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
Marsha E. Reichman PhD; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Melissa Robb ; Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Joe Selby MD, MPH; Patient-Centered Outcomes Research Institute;
Azadeh Shoaibi PhD, MHS; Sentinel Lead, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
Paul Wallace MD; Optum Labs
Janet Woodcock MD; Center for Drug Evaluation and Research, U.S. Food and Drug Administration